Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

The Therapeutic Potential of Psilocybin.

Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (44)

    1. Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
    2. From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy 2026-10-01 · Expand citations
    3. The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy 2026-10-01 · Expand citations
    4. Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network Organization 2026-09-11 · Expand citations
    5. Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis 2026-07-20 · Expand citations
    6. Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms 2026-07-01 · Expand citations
    7. Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex 2026-06-28 · Expand citations
    8. DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish 2026-06-18 · Expand citations
    9. Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development 2026-06-01 · Expand citations
    10. Psilocybin: Chemical Foundations and Emerging Therapeutic Potential 2026-06-01 · Expand citations
    11. Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons 2026-03-27 · Expand citations
    12. Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD) 2026-03-26 · Expand citations
    13. Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
    14. Psilocybin microdosing in the United States: Insights from a nationally representative survey 2026-03-08 · Expand citations
    15. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    16. Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress 2026-01-02 · Expand citations
    17. Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges 2025-12-08 · Expand citations
    18. Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications 2025-10-31 · Expand citations
    19. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review 2025-09-29 · Expand citations
    20. Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice 2025-07-06 · Expand citations
    21. Explore the effect of psilocybin on depression and anxiety 2025-07-06 · Expand citations
    22. Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
    23. Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion 2025-05-31 · Expand citations
    24. Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence 2025-05-15 · Expand citations
    25. Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties 2025-04-10 · Expand citations
    26. Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications 2025-03-07 · Expand citations
    27. BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
    28. Mushroom bioactives-polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity 2025-01-01 · Expand citations
    29. Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study 2024-09-26 · Expand citations
    30. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
    31. Psychedelic-assisted therapy: Magical thinking or a meaningful treatment for mental illness 2024-09-04 · Expand citations
    32. Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
    33. Therapeutic Implications of Psilocybin in the Wake of Decriminalization 2024-06-01 · Expand citations
    34. From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine 2024-05-01 · Expand citations
    35. A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes 2024-04-05 · Expand citations
    36. The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages 2024-01-28 · Expand citations
    37. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin 2024-01-06 · Expand citations
    38. Application of psilocybin in mental health disorders 2023-12-20 · Expand citations
    39. Pharmacists’ perspectives on psilocybin in Canada 2023-11-08 · Expand citations
    40. Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin 2023-10-12 · Expand citations
    41. Self-perception and self-recognition while looking in the mirror on psilocybin 2023-09-19 · Expand citations
    42. A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history 2023-04-26 · Expand citations
    43. Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin 2023-04-24 · Expand citations
    44. Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective 2022-10-10 · Expand citations